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Abstract 
Background: The genetic predisposition to elite athletic performance has been a controversial subject due to the 
underpowered studies and the small effect size of identified genetic variants. The aims of this study were to 
investigate the association of common single-nucleotide polymorphisms (SNPs) with endurance athlete status in a 
large cohort of elite European athletes using GWAS approach, followed by replication studies in Russian and 
Japanese elite athletes and functional validation using metabolomics analysis. 
Results: The association of 476,728 SNPs of Illumina DrugCore Gene chip and endurance athlete status was 
investigated in 796 European international-level athletes (645 males, 151 females) by comparing allelic frequencies 
between athletes specialized in sports with high (n = 662) and low/moderate (n = 134) aerobic component. 
Replication of results was performed by comparing the frequencies of the most significant SNPs between 242 and 
168 elite Russian high and low/moderate aerobic athletes, respectively, and between 60 elite Japanese endurance 
athletes and 406 controls. A meta-analysis has identified rs1052373 (GG homozygotes) in Myosin Binding Protein 
(MYBPC3; implicated in cardiac hypertrophic myopathy) gene to be associated with endurance athlete status (P = 
1.43 × 10-8, odd ratio 2.2). Homozygotes carriers of rs1052373 G allele in Russian athletes had significantly greater 
VO2 max than carriers of the AA + AG (P = 0.005). Subsequent metabolomics analysis revealed several amino acids 
and lipids associated with rs1052373 G allele (1.82 × 10-5) including the testosterone precursor androstenediol 
(3beta,17beta) disulfate. 
Conclusions: This is the first report of genome-wide significant SNP and related metabolites associated with elite 
athlete status. Further investigations of the functional relevance of the identified SNPs and metabolites in relation 
to enhanced athletic performance are warranted. 
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